drugset / Trial / NCT00030082

Hepatic Arterial Infusion With Melphalan in Treating Patients With Unresectable Liver Cancer

NCT00030082

Treatment

Summary

RATIONALE: Heating melphalan to several degrees above body temperature and infusing it to the affected area directly around the tumor may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of hepatic arterial infusion with melphalan in treating patients who have unresectable liver cancer.

Timeline

Start
2001-07
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Melphalan Small molecule Other